On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayApr 19, 2021 11:02 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Releases Statement Confirming Company in ‘Strongest Position’ Ever

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, recently reassured investors that the company is moving forward and that all aspects of the company are sound. HempFusion made the announcement in response to recent trading activity that saw its share prices fall. The company stated that its material contracts and relationships with key distributors around the world are in good standing and that all aspects of the business, including the five-channel distribution strategy, are in-motion, with no undisclosed events that would cause the share decline. All…

Continue Reading

MondayApr 19, 2021 11:00 am

Healthy Extracts Inc. (HYEX) Reinforces its Foothold in the Broader Wellness Industry

Plant-based supplements gaining popularity for treating chronic cardiovascular and neuro ailments Healthy Extracts, Inc. intensifies its foothold through its subsidiaries BergaMet North America and Ultimate Brain Nutrients The company recently announced positive results of clinical studies for two leading products, BergaMet North America’s HERHEART(TM) and UBN’s Fuel4Thought(TM) Brain Booster Plant-based diets (“PBD”) decrease the serum levels of inflammation by reducing levels of ROS (https://ibn.fm/tA2MU). Also, chronic neuropathic pain is a common debilitating problem and its treatment presents a major challenge to health care. Studies indicate that plants and some constituents of herbal medicine have the potential to cure neuropathic pain…

Continue Reading

MondayApr 19, 2021 10:53 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Applies to List Shares on NASDAQ, Is Uplisting to NEO

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has submitted an application to list its common shares on the NASDAQ Capital Market. The strategic move is designed to provide further opportunities to attract institutional and retail investors, thereby allowing the company to increase its investor base both in the United States and around the world. The move is also meant to increase visibility of the company’s growth strategy, accomplishments and results to date. The company also hopes to see increased liquidity of its common share and an enhanced overall profile, which will ultimately raise shareholder value.…

Continue Reading

MondayApr 19, 2021 10:19 am

QualityStocksNewsBreaks – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces $1M Order for Flagship Product

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has received a $1 million warehouse order for its TAAT(TM) Original, Smooth and Menthol nicotine-free, tobacco-free cigarette alternative. The order was placed by Worldwide Vape Distribution (“WWV”), a distribution company with access to more than 10,000 retail stores across 38 states. The order will be fulfilled in several batches throughout 2021 and will initially be shipped to the WWV warehouse in Dallas. WWV has positioned itself in the alternative tobacco category, boasting a strong portfolio of companies that manufacture hardware and supplies for electronic cigarettes. TAAT and WWV first signed…

Continue Reading

MondayApr 19, 2021 10:15 am

SRAX Inc. (NASDAQ: SRAX) Shows Impressive Gains with Release of Unaudited Q4 2020 Results

SRAX Inc released its unaudited financial results for 4QFY2020 on March 29, 2021 The company reported Q4 revenues of $4.5 million, up 316% YoY whilst also revealing that it had achieved $200 thousand in net income in final quarter of the year SRAX’s Sequire platform saw the number of corporate subscribers on its platform increase to 183 companies (vs 92 companies as of Q3) SRAX raised its sales guidance for FY2021 to $23-25mn, implying YoY growth rate of 164-187% SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, released its unaudited financial results for the…

Continue Reading

MondayApr 19, 2021 9:30 am

DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) Promotes New Support Portal, Social Community, Among Front-Line Healthcare Workers

The PSA campaign leveraged front-line staff real-life stories, insight and practices to raise awareness of dedicated support service tools Campaign’s success in generating engagement and reach prompted requests for additional similar endeavors in the near future DGTL and subsidiary Hashoff recently began a second activation campaign for a prominent digital sports gaming and entertainment brand following the success of an NCAA March Madness tournament-themed video-based social media campaign DGTL remains committed to building a full-service AI-powered digital media, marketing and advertising software platform to serve virtually every industry DGTL Holdings (TSX.V: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L), an innovative company focused…

Continue Reading

FridayApr 16, 2021 2:14 pm

QualityStocksNewsBreaks – RYAH Group Inc.’s Products Facilitate Personalized Therapies, Remote Patient Monitoring

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, has created a range of smart devices set to disrupt the future of medicine. RYAH Group, which is on a mission to advance the world’s transition to remote-health solutions, has done precisely that with its remote health platform called RYAH MD. “RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with RYAH’s dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on…

Continue Reading

FridayApr 16, 2021 2:06 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Finalizes Move into US Cannabis Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, has closed a purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd. in which PACR will acquire all the issued and outstanding shares. Under the arrangement, Pac Roots agreed to pay $50,000 in cash, within 30 days of the closing date, and issue 6 million common shares of the company. Lords of Grasstown traces its origin to the vision of Tyler Hazelwood, the founder and director of the iconic Lords of Gastown brand. “This acquisition marks a major milestone for the company…

Continue Reading

FridayApr 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market

Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity in the fluid management systems and accessories market, which is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a CAGR of 13.6%. These figures are according MarketsandMarkets, which cites several growth factors including technological advancements in fluid management systems (https://ibn.fm/rKWZC). As disposal of waste fluids presents a unique set of challenges for every health care facility, Skyline Medical offers a clear solution. Skyline’s patented and FDA-cleared STREAMWAY System is “the new standard in waste fluid management,” automating the collection, measurement and…

Continue Reading

FridayApr 16, 2021 1:15 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) WP1244 Potentially 500X More Potent than Daunorubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company whose lead drug candidate Berubicin has yielded promising results in the treatment of glioblastoma multiforme (“GBM”), has made equally significant strides with its second drug candidate, WP1244. Still currently in development, preclinical work for WP1244 is expected to continue during 2021 and 2022. “WP1244 is a DNA-binding agent believed to be 500-times more potent than daunorubicin in inhibiting tumor cell proliferation,” reads a recent article. “The current target indication for WP1244 includes brain cancers, pancreatic cancers, ovarian cancers and lymphoma. Preclinical studies show high uptake in the brain with antitumor activity.” On the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered